Company profile
DB · companies + sec_company_profileBaxter International Inc. (BAX) — the SEC company profile (description, website, HQ) has not been loaded for this ticker yet. Run the SEC profile loader to populate it.
AI description
Arphra AILoading cached description…
Identifiers
- SymbolBAX
- Legal nameBaxter International Inc.
- SectorHealthcare
- IndustryMedical - Instruments & Supplies
- CountryUS
- CurrencyUSD
- ExchangeNYSE
- CIK0000010456
- ISIN—
- CUSIP—
- LEI—
- Employees—
Trading
DB · key_metrics_ttmMay 02, 2026- Market cap$8.88B
- P/E (TTM)—
- P/B—
- EV / EBITDA—
- Dividend yield—
Identifiers
OpenFIGI · GLEIFCross-source keys used to bridge FMP, SEC, and non-US data.
- FIGIBBG000BCVJ77
- CountryUSA
Key executives
DB · executives| Name | Title | Compensation | Born | Since |
|---|---|---|---|---|
| Andrew Hider | Chief Executive Officer, President, Interim Group President of Medical Products & Therapies and Director | $3.49M | 1977 | — |
| Cynthia Carlisle | Executive Vice President & Chief Human Resources Officer | $1.99M | 1976 | — |
| Reazur Rasul | Executive Vice President & Group President of Healthcare Systems and Technologies | $1.36M | 1977 | — |
| Joel T. Grade | Advisor | $1.35M | 1971 | — |
| David S. Rosenbloom | Executive Vice President & General Counsel | $1.18M | 1960 | — |
| Maria Soriano | Group President of Infusion Therapies, Technologies & Pharmaceuticals | $1.1M | — | — |
| Julie Foster | President of Front Line Care | — | — | — |
| Kevin Moran | Vice President & Head of Investor Relations | — | — | — |